Michael J. Ostacher

10.2k total citations · 3 hit papers
119 papers, 6.6k citations indexed

About

Michael J. Ostacher is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Michael J. Ostacher has authored 119 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Psychiatry and Mental health, 37 papers in Clinical Psychology and 25 papers in Pharmacology. Recurrent topics in Michael J. Ostacher's work include Bipolar Disorder and Treatment (85 papers), Schizophrenia research and treatment (30 papers) and Electroconvulsive Therapy Studies (28 papers). Michael J. Ostacher is often cited by papers focused on Bipolar Disorder and Treatment (85 papers), Schizophrenia research and treatment (30 papers) and Electroconvulsive Therapy Studies (28 papers). Michael J. Ostacher collaborates with scholars based in United States, United Kingdom and Denmark. Michael J. Ostacher's co-authors include Andrew A. Nierenberg, Roy H. Perlis, Stephen R. Wisniewski, Roy H. Perlis, Michael E. Thase, David J. Miklowitz, Lauren B. Marangell, Charles L. Bowden, Joseph R. Calabrese and Michael W. Otto and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Michael J. Ostacher

109 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD)

2004 656 citations Roy H. Perlis, Lauren B. Marangell et al. profile →
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression

2007 567 citations Roy H. Perlis, Andrew A. Nierenberg et al. profile →
Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

2006 519 citations Roy H. Perlis, Michael J. Ostacher et al. American Journal of Psychiatry profile →

Peers

Michael J. Ostacher

PMH

PHARM

ECP

Joseph F. Goldberg United States

Leonardo Tondo United States

Jean‐Michel Azorin France

Adriane Ribeiro Rosa Brazil

S. Nassir Ghaemi United States

Michael Gitlin United States

Ralph Kupka Netherlands

Carla Torrent Spain

Philippe Conus Switzerland

Franco Benazzi Italy

Joseph F. Goldberg United States

Michael J. Ostacher

5.6k ×1.1

PMH

2.0k ×1.0

1.0k ×1.1

PHARM

563 ×0.8

ECP

531 ×0.8

Citations per year, relative to Michael J. Ostacher Michael J. Ostacher (= 1×) peers Joseph F. Goldberg

Countries citing papers authored by Michael J. Ostacher

Since Specialization

Citations

This map shows the geographic impact of Michael J. Ostacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Ostacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Ostacher more than expected).

Fields of papers citing papers by Michael J. Ostacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Ostacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Ostacher. The network helps show where Michael J. Ostacher may publish in the future.

Co-authorship network of co-authors of Michael J. Ostacher

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Ostacher. A scholar is included among the top collaborators of Michael J. Ostacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Ostacher. Michael J. Ostacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perlis, Roy H., Joseph F. Goldberg, Cristina Cusin, et al.. (2025). Clinical decision support for pharmacologic management of treatment-resistant depression with augmented large language models. PubMed. 12. 100142–100142.

Yang, Zeyuan, Wei Zhang, Ashwani K. Singal, et al.. (2025). Short-Term and Long-Term Outcomes Among a National Cohort of US Veterans Hospitalized for Alcohol-Associated Hepatitis. The American Journal of Gastroenterology. 121(3). 679–688.

Wong, Robert J., Derek D. Satre, Alexander Monto, et al.. (2023). Telehepatology Use and Satisfaction Among Vulnerable Cirrhosis Patients Across Three Healthcare Systems in the Coronavirus Disease Pandemic Era. SHILAP Revista de lepidopterología. 3(2). 201–209.

Duncan, Laramie E., Michael J. Ostacher, & Jacob S. Ballon. (2019). How genome-wide association studies (GWAS) made traditional candidate gene studies obsolete. Neuropsychopharmacology. 44(9). 1518–1523. 136 indexed citations

Köhler‐Forsberg, Ole, Louisa G. Sylvia, Charles L. Bowden, et al.. (2019). Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials. Acta Neuropsychiatrica. 31(4). 230–234. 3 indexed citations

Vöhringer, Paul A., Michael J. Ostacher, Rif S. El‐Mallakh, et al.. (2015). Antidepressants in Type II Versus Type I Bipolar Depression. Journal of Clinical Psychopharmacology. 35(5). 605–608. 11 indexed citations

Ostacher, Michael J., Trisha Suppes, Alan C. Swann, et al.. (2015). Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania. International Journal of Bipolar Disorders. 3(1). 11–11. 12 indexed citations

Post, Robert M., Michael J. Ostacher, & Vivek Singh. (2014). Controversies in the Psychopharmacology of Bipolar Disorder. The Journal of Clinical Psychiatry. 75(11). e30–e30. 2 indexed citations

Bowden, Charles L., Roy H. Perlis, Michael E. Thase, et al.. (2011). Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD). CNS Neuroscience & Therapeutics. 18(3). 243–249. 54 indexed citations

10.

Geddes, John, Guy M. Goodwin, Jennifer Rendell, et al.. (2010). Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. The Lancet. 375(9712). 385–395. 339 indexed citations

11.

Ghaemi, S. Nassir, Michael J. Ostacher, Rif S. El‐Mallakh, et al.. (2010). Antidepressant Discontinuation in Bipolar Depression. The Journal of Clinical Psychiatry. 71(4). 372–380. 100 indexed citations

12.

Perlis, Roy H., Michael J. Ostacher, David J. Miklowitz, et al.. (2010). Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder. The Journal of Clinical Psychiatry. 71(2). 194–200. 28 indexed citations

13.

Perlis, Roy H., Michael J. Ostacher, Joseph F. Goldberg, et al.. (2010). Transition to Mania During Treatment of Bipolar Depression. Neuropsychopharmacology. 35(13). 2545–2552. 60 indexed citations

14.

Perlis, Roy H., Michael J. Ostacher, Rudolf Uher, et al.. (2009). Stability of symptoms across major depressive episodes in bipolar disorder. Bipolar Disorders. 11(8). 867–875. 17 indexed citations

15.

Iosifescu, Dan V., Constance M. Moore, Thilo Deckersbach, et al.. (2009). Galantamine‐ER For Cognitive Dysfunction In Bipolar Disorder and Correlation with Hippocampal Neuronal Viability: A Proof‐of‐Concept Study. CNS Neuroscience & Therapeutics. 15(4). 309–319. 35 indexed citations

16.

Nierenberg, Andrew A., et al.. (2008). A Brief Review of Antidepressant Efficacy, Effectiveness, Indications, and Usage for Major Depressive Disorder. Journal of Occupational and Environmental Medicine. 50(4). 428–436. 57 indexed citations

17.

Miklowitz, David J., Michael W. Otto, Ellen Frank, et al.. (2007). Intensive Psychosocial Intervention Enhances Functioning in Patients With Bipolar Depression: Results From a 9-Month Randomized Controlled Trial. American Journal of Psychiatry. 164(9). 1340–1347. 188 indexed citations

18.

Perlis, Roy H., Michael J. Ostacher, Jayendra K. Patel, et al.. (2006). Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). American Journal of Psychiatry. 163(2). 217–224. 519 indexed citations breakdown →

19.

Ostacher, Michael J.. (2006). Pathology and Management of Treatment Resistance in Bipolar Disorder. The Psychiatric times. 23(12). 21–21. 1 indexed citations

20.

Maytal, Guy, Michael J. Ostacher, & Theodore A. Stern. (2006). Aripiprazole-Related Tardive Dyskinesia. CNS Spectrums. 11(6). 435–439. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact